Manhattan Scientifics, Inc. (MHTX)
OTCMKTS: MHTX · Delayed Price · USD
0.0100
-0.0004 (-4.31%)
Jun 30, 2022 4:00 PM - Market closed
Company Description
Manhattan Scientifics, Inc., a technology incubator, engages in the development and commercialization of life-enhancing technologies in the United States.
It develops technologies in the areas of nano-technologies and nano-medicine. The company was formerly known as Grand Enterprises, Inc. Manhattan Scientifics, Inc. was founded in 1992 and is based in New York, New York.
Manhattan Scientifics, Inc.

Country | United States |
Founded | 1992 |
Industry | Biotechnology |
Sector | Health Care |
Employees | 1 |
Contact Details
Address:
244 Fifth Avenue New York, NY 10001 United States | |
Phone | 212 541 2405 |
Stock Details
Ticker Symbol | MHTX |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | US Dollars |
CIK Code | 0001099132 |
CUSIP Number | 563122100 |
ISIN Number | US5631221000 |
Employer ID | 85-0460639 |
SIC Code | 3699 |
Key Executives
Name | Position |
---|---|
Marvin Maslow | Founder and Chairman |
Emmanuel Tsoupanarias | President, Chief Executive Officer and Director |
Leonard C. Friedman | Secretary |
Robert Romeo Proulx | President of Imagion |
Latest SEC Filings
Date | Type | Title |
---|---|---|
May 13, 2022 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
Apr 5, 2022 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
Mar 31, 2022 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Nov 15, 2021 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
Aug 23, 2021 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
Aug 16, 2021 | NT 10-Q | Notification of inability to timely file Form 10-Q or 10-QSB |
May 17, 2021 | 10-Q | Quarterly report [Sections 13 or 15(d)] |
Apr 15, 2021 | 10-K | Annual report [Section 13 and 15(d), not S-K Item 405] |
Mar 31, 2021 | NT 10-K | Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 |
Nov 16, 2020 | 10-Q | Quarterly report [Sections 13 or 15(d)] |